未登录 分享 收藏
分享 收藏
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer Denkert, Carsten; Schneeweiss, Andreas; Rey, Julia; Karn, Thomas; Hattesohl, Akira; Weber, Karsten E.; Rachakonda, Sivaramakrishna; Braun, Michael; Huober, Jens; Jank, Paul; Sinn, Hans-Peter; Zahm, Dirk-Michael; Felder, Barbel; Hanusch, Claus; Teply-Szymanski, Julia; Marme, Frederik; Fehm, Tanja; Thomalla, Jorg; V. Sinn, Bruno; Stiewe, Thorsten; Marczyk, Michal; Blohmer, Jens-Uwe; van Mackelenbergh, Marion; Schem, Christian; Staib, Peter; Link, Theresa; Muller, Volkmar; Stickeler, Elmar; Stover, Daniel G.; Solbach, Christine; Metzger-Filho, Otto; Jackisch, Christian; Geyer Jr, Charles E.; Fasching, Peter A.; Pusztai, Lajos; Nekljudova, Valentina; Untch, Michael; Loibl, Sibylle 分享 收藏
Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma 伊萨图昔单抗联合卡非佐米，来那度胺和地塞米松治疗高危新诊断多发性骨髓瘤患者的通俗语言总结 Leypoldt, Lisa B.; Tichy, Diana; Besemer, Britta; Hanel, Mathias; Raab, Marc S.; Mann, Christoph; Munder, Markus; Reinhardt, Hans Christian; Nogai, Axel; Gorner, Martin; Ko, Yon-Dschun; de Wit, Maike; Salwender, Hans; Scheid, Christof; Graeven, Ullrich; Peceny, Rudolf; Staib, Peter; Dieing, Annette; Einsele, Hermann; Jauch, Anna; Hundemer, Michael; Zago, Manola; Pozek, Ema; Benner, Axel; Bokemeyer, Carsten; Goldschmidt, Hartmut; Weisel, Katja C. 分享 收藏
Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy Harbeck, Nadia; Kates, Ronald; Schinkoethe, Timo; Schumacher, Johannes; Wuerstlein, Rachel; Degenhardt, Tom; Lueftner, Diana; Raeth, Philip; Hoffmann, Oliver; Lorenz, Ralf; Decker, Thomas; Reinisch, Mattea; Goehler, Thomas; Staib, Peter; Gluz, Oleg; Fasching, Peter A.; Schmidt, Marcus 分享 收藏
Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Wortring Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass) Gruenwald, Viktor; Ivanyi, Philipp; Zschaebitz, Stefanie; Wirth, Manfred; Staib, Peter; Schostak, Martin; Dargatz, Philip; Mueller, Lothar; Metz, Michael; Bergmann, Lothar; Steiner, Thomas; Welslau, Martin; Lorch, Anja; Rafiyan, Reza; Hellmis, Eva; Darr, Cristopher; Schuett, Philipp; Meiler, Johannes; Kretz, Thomas; Loidl, Wolfgang; Floercken, Anne; Maenz, Martin; Hinke, Axel; Hartmann, Arndt; Gruellich, Carsten 分享 收藏
Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HRD HER2L metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial Harbeck, N.; Fasching, P. A.; Wuerstlein, R.; Degenhardt, T.; Lueftner, D.; Kates, R. E.; Schumacher, J.; Raeth, P.; Hoffmann, O.; Lorenz, R.; Decker, T.; Reinisch, M.; Goehler, T.; Staib, P.; Gluz, O.; Schinkoethe, T.; Schmidt, M. 分享 收藏
分享 收藏
Prospective, Multi-Center, Artificial Intelligence Study for Early Prediction of Serious Events under Treatment Is Now Open for Recruitment in Breast Cancer - OMCAT Trial in Progress Schinkothe, Timo; Tonk, Christian Horst; Kates, Ronald; Kuemmel, Sherko; Cardoso, Fatima; Harbeck, Nadia; Staib, Peter; Schmidt, Annette 分享 收藏
Spatial and temporal heterogeneity of predictive and prognostic signatures in triple-negative breast cancer treated with neoadjuvant combination immune-chemotherapy Denkert, Carsten; Schneeweiss, Andreas; Rey, Julia; Hattesohl, Akira; Karn, Thomas; Braun, Michael; Jank, Paul; Huober, Jens; Sinn, Hans-Peter; Zahm, Dirk-Michael; Hanusch, Claus; Marme, Frederik; Furlanetto, Jenny; Thomalla, Jorg; Blohmer, Jens-Uwe; van Mackelenbergh, Marion; Stiewe, Thorsten; Staib, Peter; Jackisch, Christian; Teply-Szymanski, Julia; Fasching, Peter A.; Sinn, Bruno V.; Untch, Michael; Weber, Karsten; Loibl, Sibylle 分享 收藏
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study 60岁以上新诊断AML患者的不同治疗策略与共同标准臂 (CSA): 一项随机德国组间研究 Niederwieser, Dietger; Lang, Thomas; Krahl, Rainer; Heinicke, Thomas; Maschmeyer, Georg; Al-Ali, Haifa Kathrin; Schwind, Sebastian; Jentzsch, Madlen; Cross, Michael; Kahl, Christoph; Wolf, Hans-Heinrich; Sayer, Herbert; Schulze, Antje; Dreger, Peter; Hegenbart, Ute; Kraemer, Alwin; Junghanss, Christian; Muegge, Lars-Olof; Haehling, Detlev; Hirt, Carsten; Spaeth, Christian; Peter, Norma; Opitz, Bernhard; Florschuetz, Axel; Reifenrath, Kolja; Zojer, Niklas; Scholl, Sebastian; Poenisch, Wolfram; Heyn, Simone; Vucinic, Vladan; Hochhaus, Andreas; Aul, Carlo; Giagounidis, Aristoteles; Balleisen, Leopold; Oldenkott, Bernd; Staib, Peter; Kiehl, Michael; Schuette, Wolfgang; Naumann, Ralph; Eimermacher, Hartmut; Doerken, Bernd; Sauerland, Cristina; Lengfelder, Eva; Hiddemann, Wolfgang; Woermann, Bernhard; Mueller-Tidow, Carsten; Serve, Hubert; Schliemann, Christoph; Hehlmann, Ruediger; Berdel, Wolfgang E.; Pfirrmann, Markus; Krug, Utz; Hoffmann, Verena S. 分享 收藏
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response 新辅助durvalumab可改善早期三阴性乳腺癌的生存率，而与病理完全缓解无关 Loibl, S.; Schneeweiss, A.; Huober, J.; Braun, M.; Rey, J.; Blohmer, J. U.; Furlanetto, J.; Zahm, D. M.; Hanusch, C.; Thomalla, J.; Jackisch, C.; Staib, P.; Link, T.; Rhiem, K.; Solbach, C.; Fasching, P. A.; Nekljudova, V.; Denkert, C.; Untch, M. 分享 收藏
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial Leypoldt, Lisa B.; Besemer, Britta; Asemissen, Anne Marie; Hanel, Mathias; Blau, Igor Wolfgang; Gorner, Martin; Ko, Yon-Dschun; Reinhardt, Hans Christian; Staib, Peter; Mann, Christoph; Lutz, Raphael; Munder, Markus; Graeven, Ullrich; Peceny, Rudolf; Salwender, Hans; Jauch, Anna; Zago, Manola; Benner, Axel; Tichy, Diana; Bokemeyer, Carsten; Goldschmidt, Hartmut; Weisel, Katja C. 分享 收藏
Final results on efficacy and patient reported outcomes (PRO) of a randomized phase II trial investigating nivolumab switch-maintenance after TKI induction in metastatic clear cell renal cell carcinoma (mRCC) patients (NIVOSWITCH) Darr, C.; Zschaebitz, S.; Ivanyi, P.; Wirth, M.; Staib, P.; Schostak, M.; Mueller, L.; Metz, M.; Bergmann, L.; Steiner, T.; Lorch, A.; Schuett, P.; Rafiyan, M-R.; Hellmis, E.; Hinke, A.; Maenz, M.; Meiler, J.; Kretz, T.; Floercken, A.; Gruenwald, V. 分享 收藏
Comparison of Neoadjuvant Nab-Paclitaxe plus Carboplatin vs Nab-Paclitaxe plus Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results Gluz, Oleg; Nitz, Ulrike; Liedtke, Cornelia; Christgen, Matthias; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Bangemann, Nikola; Lindner, Christoph; Kuemmel, Sherko; Clemens, Michael; Potenberg, Jochem; Staib, Peter; Kohls, Andreas; von Schumann, Raquel; Harbeck, Nadia 分享 收藏
分享 收藏
分享 收藏
Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia Buechner, T.; Krug, U. O.; Gale, R. Peter; Heinecke, A.; Sauerland, M. C.; Haferlach, C.; Schnittger, S.; Haferlach, T.; Mueller-Tidow, C.; Stelljes, M.; Mesters, R. M.; Serve, H. L.; Braess, J.; Spiekermann, K.; Staib, P.; Grueneisen, A.; Reichle, A.; Balleisen, L.; Eimermacher, H.; Giagounidis, A.; Rasche, H.; Lengfelder, E.; Goerlich, D.; Faldum, A.; Koepcke, W.; Hehlmann, R.; Woermann, B. J.; Berdel, W. E.; Hiddemann, W. 分享 收藏
Comparison of 12 weeks neoadjuvant Nab-paclitaxel combined with carboplatinum vs. gemcitabine in triple negative breast cancer: WSG-ADAPT TN randomized phase II trial Gluz, O.; Nitz, U.; Liedtke, C.; Christgen, M.; Sotlar, K.; Grischke, E. M.; Forstbauer, H.; Braun, M.; Warm, M.; Hackmann, J.; Uleer, C.; Aktas, B.; Schumacher, C.; Bangemann, N.; Lindner, C.; Kuemmel, S.; Clemens, M.; Potenberg, J.; Staib, P.; Kohls, A.; Pelz, E.; Kates, R. E.; Wuerstlein, R.; Kreipe, H. H.; Harbeck, N. 分享 收藏
Comparison of 12 weeks neoadjuvant Nab-paclitaxel combined with carboplatinum vs. gemcitabine in triple negative breast cancer: WSG-ADAPT TN randomized phase II trial Gluz, O.; Nitz, U.; Liedtke, C.; Christgen, M.; Sotlar, K.; Grischke, E. M.; Forstbauer, H.; Braun, M.; Warm, M.; Hackmann, J.; Uleer, C.; Aktas, B.; Schumacher, C.; Bangemann, N.; Lindner, C.; Kuemmel, S.; Clemens, M.; Potenberg, J.; Staib, P.; Kohls, A.; Pelz, E.; Kates, R. E.; Wuerstlein, R.; Kreipe, H. H.; Harbeck, N. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
BMC Cancer.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏